Subsequently, we found that FGF21 was the most notably increased secretory protein that mediated the effects of hepatocyte MR deficiency and spironolactone in post-MI mice and/or patients with heart failure (HF) and dissected the regulatory mechanisms of MR on Fgf21. The gene discussed is FGF21; the disease is heart failure.